Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease

Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease

Kyung Hoon Kim,1 Hye Seon Kang,2 Ju Sang Kim,3 Hyoung Kyu Yoon,4 Sung Kyoung Kim,5 Chin Kook Rhee1 1Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, 2Division...

Full description

Bibliographic Details
Main Authors: Kim KH, Kang HS, Kim JS, Yoon HK, Kim SK, Rhee CK
Format: Article
Language:English
Published: Dove Medical Press 2017-12-01
Series:International Journal of COPD
Subjects:
phosphodiesterase-4 inhibitor
chronic obstructive pulmonary disease
body mass index
adverse event
Online Access:https://www.dovepress.com/risk-factors-for-the-discontinuation-of-roflumilast-in-patients-with-c-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/risk-factors-for-the-discontinuation-of-roflumilast-in-patients-with-c-peer-reviewed-article-COPD

Similar Items